<SEC-DOCUMENT>0001493152-23-007176.txt : 20230310
<SEC-HEADER>0001493152-23-007176.hdr.sgml : 20230310
<ACCEPTANCE-DATETIME>20230310083043
ACCESSION NUMBER:		0001493152-23-007176
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230307
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230310
DATE AS OF CHANGE:		20230310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lipocine Inc.
		CENTRAL INDEX KEY:			0001535955
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				990370688
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36357
		FILM NUMBER:		23721710

	BUSINESS ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108
		BUSINESS PHONE:		801 994 7383

	MAIL ADDRESS:	
		STREET 1:		675 ARAPEEN DRIVE, SUITE 202
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARATHON BAR CORP
		DATE OF NAME CHANGE:	20111130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:LPCN="http://lipocine.com/20230307">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_LPCN_lipocine.com_20230307 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20230307_20230307 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001535955 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityCentralIndexKey">0001535955</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lpcn-20230307.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-07to2023-03-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001535955</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-07</xbrli:startDate>
        <xbrli:endDate>2023-03-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_904_edei--DocumentType_c20230307__20230307_zN8pdCSpqfr5"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of Earliest Event Reported):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--DocumentPeriodEndDate_c20230307__20230307_zbDVXozXtOkh"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March
07, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_901_edei--EntityRegistrantName_c20230307__20230307_zxO9BtJV6B5b" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityRegistrantName">LIPOCINE
INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File No. <span id="xdx_908_edei--EntityFileNumber_c20230307__20230307_zSiWcUH9lddk"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityFileNumber">001-36357</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230307__20230307_zfl45bUB5eVl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20230307__20230307_zz1cEG7Pbp19" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityTaxIdentificationNumber">99-0370688</ix:nonNumeric></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressAddressLine1_c20230307__20230307_zw3mORQbzuGg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityAddressAddressLine1">675
Arapeen Drive</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_904_edei--EntityAddressAddressLine2_c20230307__20230307_z6Z1zPU0j9jc"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityAddressAddressLine2">Suite
202</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20230307__20230307_zVeITsTi30ga" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityAddressCityOrTown">Salt
Lake City</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20230307__20230307_zSsNVUy1SOp7"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Utah</ix:nonNumeric>
</span></span></b><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20230307__20230307_z97phfT65cX8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:EntityAddressPostalZipCode">84108</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_904_edei--CityAreaCode_c20230307__20230307_zYh54sR1P1ma"><b><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:CityAreaCode">(801)</ix:nonNumeric></b></span></span><b>
<span id="xdx_909_edei--LocalPhoneNumber_c20230307__20230307_zNndi9pxPuMb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:LocalPhoneNumber">994-7383</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
name or former address, if changed since last report: <b>Not Applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_907_edei--WrittenCommunications_c20230307__20230307_zKKVq6RXBue6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_906_edei--SolicitingMaterial_c20230307__20230307_zDVNn3AnLEU5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_903_edei--PreCommencementTenderOffer_c20230307__20230307_zMRoAlueA8Rg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230307__20230307_zT7f4lpltRVe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span id="xdx_90C_edei--Security12bTitle_c20230307__20230307_zGvDK4eg1rL2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:Security12bTitle">Common
    Stock, par value $0.0001 per share</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_905_edei--TradingSymbol_c20230307__20230307_z1l3r4lW3OSd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" name="dei:TradingSymbol">LPCN</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_900_edei--SecurityExchangeName_c20230307__20230307_z7HVzKj71J2e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167; 240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20230307__20230307_zw1Sy5BUuIrb"><ix:nonNumeric contextRef="From2023-03-07to2023-03-07" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.03.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
    Modification to Rights of Security Holders. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disclosure set forth in Item 5.03 below is hereby incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    5.03.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments
    to Articles of Incorporation or Bylaws; Change in Fiscal Year. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bylaw
Amendment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2023, the board of directors the (&#8220;<b><i>Board</i></b>&#8221;) of Lipocine Inc. (the &#8220;<b><i>Company</i></b>&#8221;),
adopted and approved an amendment to the Company&#8217;s Amended and Restated Bylaws (the &#8220;<b>Bylaws Amendment</b>&#8221;) in order
to change the number of stockholders required to constitute a quorum at a meeting of stockholders, from requiring a majority, to requiring
one-third, of the outstanding shares of stock entitled to vote, present in person, by remote communication, or represented by proxy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Bylaws Amendment does not purport to be complete and is qualified in its entirety by the text of the Bylaws
Amendment, which is filed as Exhibit 3.1 to this Current Report and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
B Preferred Stock </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 7, 2023, the Board declared a dividend of one one-thousandth of a share of Series B Preferred Stock, par value $0.0001 per share
(&#8220;<b><i>Series B Preferred Stock</i></b>&#8221;), for each outstanding share of common stock of the Company, par value $0.0001
per shares (the &#8220;<b><i>Common Stock</i></b>&#8221;) to stockholders of record at 5:00 p.m. Eastern Time on March 24, 2023 (the
&#8220;<b><i>Record Date</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General;
Transferability.</i></b> Shares of Series B Preferred Stock will be uncertificated and represented in book-entry form. No shares of Series
B Preferred Stock may be transferred by the holder thereof except in connection with a transfer by such holder of any shares of Common
Stock held by such holder, in which case a number of one one-thousandth (1/1,000th) of a share of Series B Preferred Stock equal to the
number of shares of Common Stock to be transferred by such holder will be automatically transferred to the transferee of such shares
of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Rights</i></b><i>. </i>Each share of Series B Preferred Stock will entitle the holder thereof to 1,000,000 votes per share (and, for
the avoidance of doubt, each fraction of a share of Preferred Stock will have a ratable number of votes). Thus, each one-thousandth of
a share of Series B Preferred Stock would entitle the holder thereof to 1,000 votes. The outstanding shares of Series B Preferred Stock
will vote together with the outstanding shares of Common Stock of the Company as a single class exclusively with respect to (i) any proposal
to adopt an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended (the &#8220;<b><i>Certificate
of Incorporation</i></b>&#8221;), to effect a reverse stock split of the outstanding shares of Common Stock at a ratio determined in
accordance with the terms of such amendment (the &#8220;<b><i>Reverse Stock Split</i></b>&#8221;), and (ii) any proposal to adjourn any
meeting of stockholders called for the purpose of voting on Reverse Stock Split (the &#8220;<b><i>Adjournment Proposal</i></b>&#8221;).
The Series B Preferred Stock will not be entitled to vote on any other matter, except to the extent required under the Delaware General
Corporation Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise provided on any applicable proxy or ballot with respect to the voting on the Reverse Stock Split or the Adjournment Proposal,
the vote of each share of Series B Preferred Stock (or fraction thereof) entitled to vote on the Reverse Stock Split, the Adjournment
Proposal or any other matter brought before any meeting of stockholders held to vote on the Reverse Stock Split and the Adjournment Proposal
will be cast in the same manner as the vote, if any, of the share of Common Stock in respect of which such share of Series B Preferred
Stock (or fraction thereof) was issued as a dividend is cast on the Reverse Stock Split, the Adjournment Proposal, or such other matter,
as applicable, and the proxy or ballot with respect to shares of Common Stock held by any holder on whose behalf such proxy or ballot
is submitted will be deemed to include all shares of Series B Preferred Stock (or fraction thereof) held by such holder. Holders of Series
B Preferred Stock will not receive a separate ballot or proxy to cast votes with respect to the Series B Preferred Stock on the Reverse
Stock Split, the Adjournment Proposal, or any other matter brought before any meeting of stockholders held to vote on the Reverse Stock
Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividend
Rights</i></b>. The holders of Series B Preferred Stock, as such, will not be entitled to receive dividends of any kind.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation
Preference</i></b>. The Series B Preferred Stock will rank senior to the Common Stock and junior to each other series or class of the
Company&#8217;s preferred stock issued either before or after the issuance of the Series B Preferred Stock, unless the terms of any such
series shall provide otherwise, as to any distribution of assets upon a liquidation, dissolution or winding up of the Company, whether
voluntarily or involuntarily (a &#8220;<b><i>Dissolution</i></b>&#8221;). Upon any Dissolution, each holder of outstanding shares of
Series B Preferred Stock will be entitled to be paid out of the assets of the Company available for distribution to stockholders, prior
and in preference to any distribution to the holders of Common Stock, an amount in cash equal to $0.001 per outstanding share of Series
B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption</i></b>.
All shares of Series B Preferred Stock that are not present in person or by proxy at any meeting of stockholders held to vote on the
Reverse Stock Split and the Adjournment Proposal as of immediately prior to the opening of the polls at such meeting (the &#8220;<b><i>Initial
Redemption Time</i></b>&#8221;) will automatically be redeemed in whole, but not in part, by the Company at the Initial Redemption Time
without further action on the part of the Company or the holder of shares of Series B Preferred Stock (the &#8220;<b><i>Initial Redemption</i></b>&#8221;).
Any outstanding shares of Series B Preferred Stock that have not been redeemed pursuant to an Initial Redemption will be redeemed in
whole, but not in part, (i) if such redemption is ordered by the Board in its sole discretion, automatically and effective on such time
and date specified by the Board in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Certificate
of Incorporation implementing the Reverse Stock Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of Series B Preferred Stock redeemed in any redemption described above will be redeemed in consideration for the right to receive
an amount equal to $0.01 in cash for each ten whole shares of Series B Preferred Stock that are &#8220;beneficially owned&#8221; by the
&#8220;beneficial owner&#8221; (as such terms are defined in the certificate of designation with respect to the Series B Preferred Stock
(the &#8220;<b><i>Certificate of Designation</i></b>&#8221;)) thereof as of immediately prior to the applicable redemption time and redeemed
pursuant to such redemption, payable upon receipt by the Company of a written request submitted by the applicable holder to the corporate
secretary of the Company (each a &#8220;<b><i>Redemption Payment Request</i></b>&#8221;) following the applicable redemption time. Such
Redemption Payment Request shall (i) be in a form reasonably acceptable to the Company, (ii) set forth in reasonable detail the number
of shares of Series B Preferred Stock beneficially owned by the holder at the applicable redemption time and include evidence reasonably
satisfactory to the Company regarding the same, and (iii) set forth a calculation specifying the amount in cash owed to such holder by
the Company with respect to the shares of Series B Preferred Stock that were redeemed at the applicable redemption time. However, the
redemption consideration in respect of the shares of Series B Preferred Stock (or fractions thereof) redeemed in any redemption described
above: (i) will entitle the former beneficial owners of less than ten whole shares of Preferred Stock redeemed in any redemption to no
cash payment in respect thereof and (ii) will, in the case of a former beneficial owner of a number of shares of Series B Preferred Stock
(or fractions thereof) redeemed pursuant to any redemption that is not equal to a whole number that is a multiple of ten, entitle such
beneficial owner to the same cash payment, if any, in respect of such redemption as would have been payable in such redemption to such
beneficial owner if the number of shares (or fractions thereof) beneficially owned by such beneficial owner and redeemed pursuant to
such redemption were rounded down to the nearest whole number that is a multiple of ten (such, that for example, the former beneficial
owner of 25 shares of Series B Preferred Stock redeemed pursuant to any redemption will be entitled to receive the same cash payment
in respect of such redemption as would have been payable to the former beneficial owner of 20 shares of Series B Preferred Stock redeemed
pursuant to such redemption).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities
of the Company. The Series B Preferred Stock has no stated maturity and is not subject to any sinking fund. The Series B Preferred Stock
is not subject to any restriction on the redemption or repurchase of shares by the Company while there is any arrearage in the payment
of dividends or sinking fund installments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Designation was filed with the Delaware Secretary of State and became effective on March 10, 2023. The foregoing description
of the Series B Preferred Stock does not purport to be complete and is qualified in its entirety by reference to the Certificate of Designation,
which is filed as Exhibit 3.2 to this Current Report and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD Disclosure. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 10, 2023, the Company issued a press release announcing the Series B Preferred Stock dividend. A copy of that press release is
furnished as Exhibit 99.1 to this Current Report and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
    No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Amendment to the Amended and Restated Bylaws of Lipocine Inc.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-2.htm">Certificate of Designation of the Series B Preferred Stock of the Company, dated March 10, 2023</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex99-1.htm">Press
    Release announcing &#8220;Lipocine Announces Pro Rata Distribution of Series B Preferred Stock to its Holders of Common Stock&#8221;
    filed March 10, 2023</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIPOCINE
    INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    10, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Mahesh V. Patel</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahesh
    V. Patel</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk1bqtJHi4pYRYqIr9FuJdhmyyb+HclbGlvEZWFZZr4ZIQZiSQtdI8NxVuSwx6atlUMosEJGc0bvyFbrFPwt8KKtY2Vc9/7AjDyDnkmG4eTkhc561xbLFGQ8ktNRFIMcpzKB3UYEXz0jU+kSjdOqBmVK2DG1rNEpfvUJe/UkQ82rqzogW00mhXAoe/kNkQwj2NJdPYivFvI8E8Ggm0AsmW7tt+ZmHTUwr7HxXbZH/xt8ABxWSVA= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
TO THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED BYLAWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
LIPOCINE INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, in his capacity as the President and Chief Executive Officer of Lipocine Inc. (the &ldquo;<I>Corporation</I>&rdquo;), hereby
certifies on behalf of the Corporation that the following Amendment to the Amended and Restated Bylaws of the Corporation (the &ldquo;<I>Bylaws</I>&rdquo;)
was duly adopted by the Board of Directors of the Corporation on March 7, 2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
                                            8 of the Bylaws is hereby amended and restated in its entirety to read as follows:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Section
8. Quorum. At all meetings of stockholders, except where otherwise provided by statute or by the Certificate of Incorporation, or by
these Bylaws, the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of one-third
(1/3) of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction of business. In the absence of
a quorum, any meeting of stockholders may be adjourned, from time to time, either by the chairperson of the meeting or by vote of the
holders of a majority of the shares represented thereat, but no other business shall be transacted at such meeting. The stockholders
present at a duly called or convened meeting, at which a quorum is present, may continue to transact business until adjournment, notwithstanding
the withdrawal of enough stockholders to leave less than a quorum. Except as otherwise provided by statute or by applicable stock exchange
rules, or by the Certificate of Incorporation or these Bylaws, in all matters other than the election of directors, the affirmative vote
of the majority of shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and entitled
to vote generally on the subject matter shall be the act of the stockholders. Except as otherwise provided by statute, the Certificate
of Incorporation or these Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication,
if applicable, or represented by proxy at the meeting and entitled to vote generally on the election of directors. Where a separate vote
by a class or classes or series is required, except where otherwise provided by the statute or by the Certificate of Incorporation or
these Bylaws, one-third (1/3) of the outstanding shares of such class or classes or series, present in person, by remote communication,
if applicable, or represented by proxy duly authorized, shall constitute a quorum entitled to take action with respect to that vote on
that matter. Except where otherwise provided by statute or by the Certificate of Incorporation or these Bylaws, the affirmative vote
of the majority (plurality, in the case of the election of directors) of shares of such class or classes or series present in person,
by remote communication, if applicable, or represented by proxy at the meeting shall be the act of such class or classes or series.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            other provisions of the Bylaws remain in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 7, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Mahesh V. Patel</I></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahesh
                                            V. Patel</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ex3-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 3.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>LIPOCINE INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CERTIFICATE OF DESIGNATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SERIES B PREFERRED STOCK </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pursuant to Section 151 of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">General Corporation Law of the State of Delaware</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of
Lipocine Inc., a Delaware corporation (the &ldquo;<B>Corporation</B>&rdquo;), that the following resolution was duly adopted by the board
of directors of the Corporation (the &ldquo;<B>Board of Directors</B>&rdquo;), in accordance with the provisions of Section 151 of the
General Corporation Law of the State of Delaware, as amended (the &ldquo;<B>DGCL</B>&rdquo;), at a meeting duly called and held on March
7, 2023, which resolution provides for the creation of a series of the Corporation&rsquo;s Preferred Stock, par value $0.001 per share,
which is designated as &ldquo;Series B Preferred Stock,&rdquo; with the rights, powers and preferences, and the qualifications, limitations
and restrictions thereof, set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>WHEREAS</B>, the Amended and Restated Certificate
of Incorporation of the Corporation (as amended, the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), provides for a class of capital
stock of the Corporation known as preferred stock, consisting of 10,000,000 shares, par value $0.0001 per share (the &ldquo;<B>Preferred
Stock</B>&rdquo;), issuable from time to time in one or more series, and further provides that the Board of Directors is expressly authorized,
subject to limitations prescribed by law, to provide for the issuance of the shares of Preferred Stock in one or more series, and by filing
a certificate of designation pursuant to the DGCL, to establish from time to time the number of shares to be included in each such series,
and to fix the designation, powers (including voting powers), preferences and rights of each such series and the qualifications, limitations
or restrictions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>NOW, THEREFORE, BE IT RESOLVED</B>, that, pursuant
to authority conferred upon the Board of Directors by the Certificate of Incorporation, (i) a series of Preferred Stock be, and hereby
is, authorized by the Board of Directors, (ii) the Board of Directors hereby authorizes the issuance of 200,000 shares of Series B Preferred
Stock and (iii) the Board of Directors hereby fixes the designations, powers, preferences and rights, and the qualifications, limitations
or restrictions thereof, of such shares of Preferred Stock, in addition to any provisions set forth in the Certificate of Incorporation
that are applicable to all series of the Preferred Stock, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TERMS OF PREFERRED STOCK </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <U>Designation, Amount and Par Value</U>. The series
of Preferred Stock created hereby shall be designated as the Series B Preferred Stock (the &ldquo;<B>Series B Preferred Stock</B>&rdquo;),
and the number of shares so designated shall be 200,000. Each share of Series B Preferred Stock shall have a par value of $0.0001 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <U>Dividends</U>. The holders of Series B Preferred
Stock, as such, shall not be entitled to receive dividends of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <U>Voting Rights</U>. Except as otherwise provided
by the Certificate of Incorporation or required by law, the holders of shares of Series B Preferred Stock shall have the following voting
rights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3.1 Except as otherwise provided herein, each outstanding
share of Series B Preferred Stock shall have 1,000,000 votes per share (and, for the avoidance of doubt, each fraction of a share of Series
B Preferred Stock shall have a ratable number of votes). The outstanding shares of Series B Preferred Stock shall vote together with the
outstanding shares of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Corporation as a single
class exclusively with respect to the Reverse Stock Split (as defined below) and the Adjournment Proposal (as defined below) and shall
not be entitled to vote on any other matter except to the extent required under the DGCL. Notwithstanding the foregoing, and for the avoidance
of doubt, each share of Series B Preferred Stock (or fraction thereof) redeemed pursuant to the Initial Redemption (as defined below)
shall have no voting power with respect to, and the holder of each share of Series B Preferred Stock (or fraction thereof) redeemed pursuant
to the Initial Redemption shall have no voting power with respect to any such share of Series B Preferred Stock (or fraction thereof)
on, the Reverse Stock Split, the Adjournment Proposal, or any other matter brought before any meeting of stockholders held to vote on
the Reverse Stock Split. As used herein, the term &ldquo;<B>Reverse Stock Split</B>&rdquo; means any proposal to adopt an amendment to
the Certificate of Incorporation to reclassify the outstanding shares of Common Stock into a smaller number of shares of Common Stock
at a ratio specified in or determined in accordance with the terms of such amendment. As used herein, the term &ldquo;<B>Adjournment Proposal</B>&rdquo;
means any proposal to adjourn any meeting of stockholders called for the purpose of voting on Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3.2 Unless otherwise provided on any applicable proxy
or ballot with respect to the voting on the Reverse Stock Split or Adjournment Proposal, the vote of each share of Series B Preferred
Stock (or fraction thereof) entitled to vote on the Reverse Stock Split, the Adjournment Proposal, or any other matter brought before
any meeting of stockholders held to vote on the Reverse Stock Split or Adjournment Proposal shall be cast in the same manner as the vote,
if any, of the share of Common Stock (or fraction thereof) in respect of which such share of Series B Preferred Stock (or fraction thereof)
was issued as a dividend is cast on the Reverse Stock Split, Adjournment Proposal, or such other matter, as applicable, and the proxy
or ballot with respect to shares of Common Stock held by any holder on whose behalf such proxy or ballot is submitted will be deemed to
include all shares of Series B Preferred Stock (or fraction thereof) held by such holder. Holders of Series B Preferred Stock will not
receive a separate ballot or proxy to cast votes with respect to the Series B Preferred Stock on the Reverse Stock Split or any other
matter brought before any meeting of stockholders held to vote on the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">4. <U>Rank; Liquidation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4.1 The Series B Preferred Stock shall rank senior
to the Common Stock and junior to each other series or class of the Company&rsquo;s preferred stock issued either before or after the
issuance of the Series B Preferred Stock, unless the terms of any such series shall provide otherwise, as to any distribution of assets
upon a liquidation, dissolution or winding up of the Corporation, whether voluntarily or involuntarily (a &ldquo;<B>Dissolution</B>&rdquo;).
For the avoidance of any doubt, but without limiting the foregoing, neither the merger or consolidation of the Corporation with or into
any other entity, nor the sale, lease, exchange or other disposition of all or substantially all of the Corporation&rsquo;s assets shall,
in and of itself, be deemed to constitute a Dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4.2 Upon any Dissolution, each holder of outstanding
shares of Series B Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to stockholders,
prior and in preference to any distribution to the holders of Common Stock, an amount in cash equal to $0.001 per outstanding share of
Series</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">B Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">5. <U>Redemption</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.1 All shares of Series B Preferred Stock that are
not present in person or by proxy at any meeting of stockholders held to vote on the Reverse Stock Split and the Adjournment Proposal
as of immediately prior to the opening of the polls at such meeting (the &ldquo;<B>Initial Redemption Time</B>&rdquo;) shall automatically
be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof
(the &ldquo;<B>Initial Redemption</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.2 Any outstanding shares of Series B Preferred Stock
that have not been redeemed pursuant to an Initial Redemption shall be redeemed in whole, but not in part, (i) if such redemption is ordered
by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors
in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Certificate of Incorporation implementing
the Reverse Stock Split (any such redemption pursuant to this Section 5.2, the &ldquo;<B>Subsequent Redemption</B>&rdquo; and, together
with the Initial Redemption, the &ldquo;<B>Redemptions</B>&rdquo;). As used herein, the &ldquo;<B>Subsequent Redemption Time</B>&rdquo;
shall mean the effective time of the Subsequent Redemption, and the &ldquo;<B>Redemption Time</B>&rdquo; shall mean (i) with respect to
the Initial Redemption, the Initial Redemption Time and (ii) with respect to the Subsequent Redemption, the Subsequent Redemption Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.3 Each share of Series B Preferred Stock redeemed
in any Redemption pursuant to this Section 5 shall be redeemed in consideration for the right to receive an amount equal to $0.01 in cash
for each ten whole shares of Series B Preferred Stock that are &ldquo;beneficially owned&rdquo; by the &ldquo;beneficial owner&rdquo;
(as such terms are defined below) thereof as of immediately prior to the applicable Redemption Time and redeemed pursuant to such Redemption,
payable upon receipt by the Corporation of a written request submitted by the applicable holder to the corporate secretary of the Corporation
(each a &ldquo;<B><I>Redemption Payment Request</I></B>&rdquo;) following the applicable redemption time. Such Redemption Payment Request
shall (i) be in a form reasonably acceptable to the Corporation (ii) set forth in reasonable detail the number of shares of Series B Preferred
Stock beneficially owned by the holder at the applicable Redemption Time and include evidence reasonably satisfactory to the Corporation
regarding the same, and (iii) set forth a calculation specifying the amount in cash owed to such holder by the Corporation with respect
to the shares of Series B Preferred Stock that were redeemed at the applicable Redemption Time; provided, however, that for the avoidance
of doubt, the redemption consideration in respect of the shares of Series B Preferred Stock (or fractions thereof) redeemed in any Redemption
pursuant to this Section 5: (x) shall entitle the former beneficial owners of less than ten whole shares of Series B Preferred Stock redeemed
in any Redemption to no cash payment in respect thereof and (y) shall, in the case of a former beneficial owner of a number of shares
of Series B Preferred Stock (or fractions thereof) redeemed pursuant to any Redemption that is not equal to a whole number that is a multiple
of ten, entitle such beneficial owner to the same cash payment, if any, in respect of such Redemption as would have been payable in such
Redemption to such beneficial owner if the number of shares (or fractions thereof) beneficially owned by such beneficial owner and redeemed
pursuant to such Redemption were rounded down to the nearest whole number that is a multiple of ten (such, that for example, the former
beneficial owner of 25 shares of Series B Preferred Stock redeemed pursuant to any Redemption shall be entitled to receive the same cash
payment in respect of such Redemption as would have been payable to the former beneficial owner of 20 shares of Series B Preferred Stock
redeemed pursuant to such Redemption). As used herein, &ldquo;<B>Person</B>&rdquo; shall mean any individual, firm, corporation, partnership,
limited liability company, trust or other entity, and shall include any successor (by merger or otherwise) to such entity. As used herein,
a Person shall be deemed the &ldquo;<B>beneficial owner</B>&rdquo; of, and shall be deemed to &ldquo;<B>beneficially own</B>,&rdquo; any
securities which such Person is deemed to beneficially own, directly or indirectly, within the meaning of Rule l3d-3 of the General Rules
and Regulations under the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5.4 From and after the time at which any shares of
Series B Preferred Stock are called for redemption (whether automatically or otherwise) in accordance with Section 5.1 or Section 5.2,
such shares of Series B Preferred Stock shall cease to be outstanding, and the only right of the former holders of such shares of Series
B Preferred Stock, as such, will be to receive the applicable redemption price, if any. The shares of Series B Preferred Stock redeemed
by the Corporation pursuant to this Certificate of Designation shall, upon such redemption, be automatically retired and restored to the
status of authorized but unissued shares of Preferred Stock. Notwithstanding anything to the contrary herein or otherwise, and for the
avoidance of doubt, any shares of Series B Preferred Stock (or fraction thereof) that have been redeemed pursuant to an Initial Redemption
shall not be deemed to be outstanding for the purpose of voting or determining the number of votes entitled to vote on any matter submitted
to stockholders (including the Reverse Stock Split or any other matter brought before any meeting of stockholders held to vote on the
Reverse Stock Split) from and after the time of the Initial Redemption. Notice of any meeting of stockholders for the submission to stockholders
of any proposal to approve the Reverse Stock Split shall constitute notice of (i) a redemption of shares of Series B Preferred Stock pursuant
to an Initial Redemption and result in the automatic redemption of the applicable shares of Series B Preferred Stock (and/or fractions
thereof) pursuant to the Initial Redemption at the Initial Redemption Time pursuant to Section 5.1 hereof and (ii) a redemption of shares
of Series B Preferred Stock pursuant to a Subsequent Redemption and result in the automatic redemption of the applicable shares of Series
B Preferred Stock (and/or fractions thereof) pursuant to the Subsequent Redemption at the Subsequent Redemption Time pursuant to Section
5.2 hereof. In connection with the filing of this Certificate of Designation, the Corporation has set apart funds for payment for the
redemption of all shares of Series B Preferred Stock pursuant to the Redemptions and shall continue to keep such funds apart for such
payment through the payment of the purchase price for the redemption of all such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. <U>Transfer</U>. Shares of Series B Preferred Stock
will be uncertificated and represented in book-entry form. No shares of Series B Preferred Stock may be transferred by the holder thereof
except in connection with a transfer by such holder of any shares of Common Stock held thereby, in which case a number of one one-thousandths
(1/1,000ths) of a share of Series B Preferred Stock equal to the number of shares of Common Stock to be transferred by such holder shall
be automatically transferred to the transferee of such shares of Common Stock. Notice of the foregoing restrictions on transfer shall
be given in accordance with Section 151 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7. <U>Fractional Shares</U>. The Series B Preferred
Stock may be issued in whole shares or in any fraction of a share that is one one-thousandth (1/1,000th) of a share or any integral multiple
of such fraction, which fractions shall entitle the holder, in proportion to such holder&rsquo;s fractional shares, to exercise voting
rights, participate in distributions upon a Dissolution and have the benefit of any other rights of holders of Series B Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8. <U>Severability</U>. Whenever possible, each provision
hereof shall be interpreted in a manner as to be effective and valid under applicable law, but if any provision hereof is held to be prohibited
by or invalid under applicable law, then such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating or otherwise adversely affecting the remaining provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">[<I>Remainder of Page Intentionally
Left Blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IN WITNESS WHEREOF, Lipocine Inc. has caused this
Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock to be duly executed by the undersigned duly
authorized officer as of this 10th day of March, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIPOCINE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Mahesh V. Patel</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahesh V. Patel</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Lipocine Announces Pro Rata Distribution of Series
B Preferred Stock to its Holders of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>SALT LAKE CITY, MARCH 10, 2023</B> &mdash; Lipocine
Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that its
Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series B Preferred Stock, par value $0.0001
per share, for each outstanding share of the Company&rsquo;s common stock held of record as of 5:00 p.m. Eastern Time on March 24, 2023.
The shares of Series B Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Time on March 24, 2023. The outstanding
shares of Series B Preferred Stock will vote together with the outstanding shares of the Company&rsquo;s common stock, as a single class,
exclusively with respect to a reverse stock split, as well as any proposal to adjourn any meeting of stockholders called for the purpose
of voting on the reverse stock split, and will not be entitled to vote on any other matter, except to the extent required under the Delaware
General Corporation Law. Subject to certain limitations, each outstanding share of Series B Preferred Stock will have 1,000,000 votes
per share (or 1,000 votes per one one-thousandth of a share of Series B Preferred Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All shares of Series B Preferred Stock that are not
present in person or by proxy at the meeting of stockholders held to vote on the reverse stock split as of immediately prior to the opening
of the polls at such meeting will automatically be redeemed by the Company. Any outstanding shares of Series B Preferred Stock that have
not been so redeemed will be redeemed if such redemption is ordered by the Company&rsquo;s Board of Directors or automatically upon the
approval by the Company&rsquo;s stockholders of an amendment to the Company&rsquo;s certificate of incorporation effecting the reverse
stock split at such meeting. After the redemption of the Series B Preferred Stock, the Company&rsquo;s capitalization structure will be
as it was prior to the dividend of the Series B Preferred Stock, with the same number of common shares outstanding as were outstanding
prior to the March 24, 2023 dividend of the Series B Preferred Stock, without giving effect to the issuance of common stock in connection
with a stock option exercise or other sales of common stock by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series B Preferred Stock will be uncertificated,
and no shares of Series B Preferred Stock will be transferable by any holder thereof except in connection with a transfer by such holder
of any shares of the Company&rsquo;s common stock held by such holder. In that case, a number of one one-thousandth of a share of Series
B Preferred Stock equal to the number of shares of the Company&rsquo;s common stock to be transferred by such holder would be transferred
to the transferee of such shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further details regarding the Series B Preferred Stock
will be contained in a report on Form 8-K to be filed by the Company with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>About Lipocine Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Lipocine is a biopharmaceutical
company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop products for
CNS disorders. Lipocine has candidates in development as well as candidates for which we are exploring partnering. Our candidates represent
enablement of patient friendly oral delivery options for favorable benefit to risk profile which target large addressable markets with
significant unmet medical needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Lipocine clinical development
candidates include: LPCN 1154, oral brexanolone, for the potential treatment of postpartum depression, LPCN 2101 for the potential treatment
of epilepsy and LPCN 1148, an oral prodrug of bioidentical testosterone targeted for the management of symptoms associated with liver
cirrhosis. Lipocine is exploring partnering for LPCN 1107, our candidate for prevention of pre-term birth, LPCN 1148, LPCN 1144, our candidate
for treatment of non-cirrhotic NASH, and LPCN 1111, a once-a-day therapy candidate for testosterone replacement therapy (TRT). TLANDO,
a novel oral prodrug of testosterone containing testosterone undecanoate developed by Lipocine, is approved by the FDA for conditions
associated with a deficiency of endogenous testosterone, also known as hypogonadism, in adult males. For more information, please visit
<U>www.lipocine.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This release contains &ldquo;forward-looking statements&rdquo;
that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements that
are not historical facts regarding the Company&rsquo;s 2023 annual meeting, any potential reverse stock split, the redemption of the Series
B Preferred Stock, and the Company&rsquo;s capital structure. Investors are cautioned that all such forward-looking statements involve
risks and uncertainties, including, without limitation, the risks that we may not be successful in developing product candidates to treat
CNS disorders, we may not be able to enter into partnerships or other strategic relationships to monetize our non-core assets, the FDA
will not approve any of our products, risks related to our products, expected product benefits not being realized, clinical and regulatory
expectations and plans not being realized, new regulatory developments and requirements, risks related to the FDA approval process including
the receipt of regulatory approvals, the results and timing of clinical trials, patient acceptance of Lipocine&rsquo;s products, the manufacturing
and commercialization of Lipocine&rsquo;s products, and other risks detailed in Lipocine&rsquo;s filings with the SEC, including, without
limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Lipocine
assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>CONTACT: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Krista Fogarty</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Phone: (801) 994-7383</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><U>kf@lipocine.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Investors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">PJ Kelleher</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Phone: (617) 430-7579</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>pkelleher@lifesciadvisors.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ ,\# 2(  A$! Q$!_\0
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MT5[IM_##=6TJ21@U_))_P3@UWX@_\$IO^"L_CW_@GCXUU^_UCX(?'+6X]/\
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M.NOVDOV>+K5;;3KGQO//9ZXIAN7MH53P_P#%S1K&.]TS75@B=['1OB/IT_\
M:=Q++;PQ0,6N[?\ L<KDO'G@/P9\4/!OB3X>_$/PUH_C'P3XOTF[T+Q+X9UZ
MRBO])UC2KZ,Q7%K=VTRE2""'AE0I/;3I%<VTL-Q#%*@!^?'C3]MSX>_M&?\
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2"+KQ=6'L*,93C)SKRG6M)?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>lpcn-20230307.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOP2bP9z5Z8iekhvWBybbmKHyskNRQCKS00avb2EUQJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:LPCN="http://lipocine.com/20230307" elementFormDefault="qualified" targetNamespace="http://lipocine.com/20230307">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://lipocine.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="lpcn-20230307_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lpcn-20230307_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>lpcn-20230307_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>lpcn-20230307_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lipocine.com/role/Cover" xlink:href="lpcn-20230307.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lipocine.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139694633764000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  07,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIPOCINE
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001535955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">99-0370688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">675
Arapeen Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt
Lake City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">994-7383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LPCN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lpcn-20230307.xsd" xlink:type="simple"/>
    <context id="From2023-03-07to2023-03-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001535955</identifier>
        </entity>
        <period>
            <startDate>2023-03-07</startDate>
            <endDate>2023-03-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-07to2023-03-07">0001535955</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-07to2023-03-07">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-03-07to2023-03-07">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-03-07to2023-03-07">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-07to2023-03-07">2023-03-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-07to2023-03-07">LIPOCINE INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="From2023-03-07to2023-03-07">001-36357</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-07to2023-03-07">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-07to2023-03-07">99-0370688</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-07to2023-03-07">675 Arapeen Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-03-07to2023-03-07">Suite 202</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-07to2023-03-07">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-03-07to2023-03-07">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-07to2023-03-07">84108</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-07to2023-03-07">(801)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-07to2023-03-07">994-7383</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-07to2023-03-07">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-07to2023-03-07">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-07to2023-03-07">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-07to2023-03-07">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-07to2023-03-07">Common     Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-07to2023-03-07">LPCN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-07to2023-03-07">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-07to2023-03-07">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MU$-J5A FJ F&!   O1$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF%USXC84AN_S*S1NI[,[$^(/OE-@ACALRVR6T,!VI^WT0M@"-+$MKR2'Y-_W
MR(!-L^:87 3+]GG]2#IZC^S!3LAGM65,D]<X2M30VFJ=WMJV"K8LINI&I"R!
M*VLA8ZJA*3>V2B6C81X41[;G.!T[ICRQ1H/\W%R.!B+3$4_87!*5Q3&5;W<L
M$KNAY5K'$T]\L]7FA#T:I'3#%DQ_3><26G:A$O*8)8J+A$BV'EIC]_;.ZYB
M_(X_.=NIDV-BNK(2XMDTIN'0<@P1BUB@C02%GQ?FLR@R2L#Q_2!J%<\T@:?'
M1_5/>>>A,RNJF"^B;SS4VZ'5LTC(UC2+])/8_<X.'6H;O4!$*O]/=OM[6RV+
M!)G2(CX$ T',D_TO?3T,Q&E YTR =PCP<N[]@W+*>ZKI:"#%CDAS-ZB9@[RK
M>33 \<3,RD)+N,HA3H]\\<+DP-8@94[8P2'L;A_FG0G[0N4-<;K7Q'.\YO_#
M;2 H,+P"P\OUFA@&^6>\4EK"1/U;1;17:%4KF.R]52D-V-""]%1,OC!K],M/
M;L?Y%>%K%GQ-3'UT+X(,<E&3Y5O*JN#P\%[C,P+1*B!:J,H8",*<XE-$-U44
M>/R:1HHA'.V"HWW98,R9Y"(DDR0DD'R5XX(KY6F4YU%=(G4*M@ZJZ&=2YB/$
M54 C\A>C$N7#U1H-UVLT782K6W!U4:5)HKE^ ZR(D5D6KZH7':[A.&ZCV6FV
MNPA/K^#I7<+SQ#;<+#D8L1F-*T<(UWF8SA_]Z6QR-9WY-PA7O^#J7\+EPQQ*
MF+]I$K)7\IF]59'A2@X,5[O9[K?;");KE#[I7 *VI*]D&@(=7_. YH7E_'36
M2/;[#:?9=3J]'D9XXN3N)833)! R%3*'NR8+#9E/A"2^R&!,86A%6#G/->KW
M$PRR]'D7M>DCY#@,P:35]?& /,!]Y#&I)L,E.]WVU5C2E+&$W$NH\1AH:?@N
M;MDHZ'(G*D%QR47&-;L"H\, RV+@XF[^'M W+9CGI=@EE7"XW()&^NJ!/K-<
M"",LRX2+N_M[PB(5YU*\\"2HGFQ<\^L20RNKA(L;^WNTN5 :[.9OGIY?'[AB
MK^4ZZ#HN*X6+VWP^D6/88I]'P04^]!SW(X92%@FWQMV%*:+SK4BPJE4CTN^W
M&MUF#ZON;ED>7-S5OTFN-2QT7\1QEAPL6%52X4)UFR&OK P>;N,+$?& :YYL
MR!=(<,EI5+E]Q55J><HZX.%./9>L$<#P,%AA^STK;!MA=_VX7E?/7XU>+=G)
M)A]WZA_(IDIE0%8+B,O6 I:F[^$.O>0:]F=B35SOP^HC6; @DS^XX8$)5S+Y
M*9(K G\++8+G:Y+"3O2%1ADC/SLW9G-"4NBSVE*)LI?UP,,-?"EI:')P\1:O
M1'4&X@(/<W^&D92^[^$>?1PV,GD-MC39L+-[RQJAV7AQ/_X#8RH-W[O(\"<Q
MDQLS2K^!@MX:&TEI4CW!N.#9I+-/7L;-APUXQX$G*A*Q-0@Y-UWHL]Q_*]@W
MM$CS]_.5T/"VGQ]N&84%86Z ZVLA]+%A7OF++S:C_P!02P,$%     @ U$-J
M5I^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)J
MXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN
M6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9
MWMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+
ME)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64
M,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).
MIF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3
M"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^
MFO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA
M6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;
M^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.
MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ U$-J5@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" #40VI60'XP$NT    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " #40VI6F5R<(Q &  "<)P  $P
M    @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -1#:E80
M)J@)A@0  +T1   8              " @0P(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " #40VI6GZ ;\+$"  #B#   #0
M    @ '(#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -1#:E:7BKL<P
M !,"   +              "  :0/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M -1#:E:JQ"(6,P$  "("   /              "  8T0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #40VI6)!Z;HJT   #X 0  &@
M@ 'M$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #4
M0VI699!YDAD!  #/ P  $P              @ '2$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"   <%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lipocine.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex3-1.htm</File>
    <File>ex3-2.htm</File>
    <File>ex99-1.htm</File>
    <File>lpcn-20230307.xsd</File>
    <File>lpcn-20230307_lab.xml</File>
    <File>lpcn-20230307_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lpcn-20230307_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lpcn-20230307_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lpcn-20230307.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "LPCN",
   "nsuri": "http://lipocine.com/20230307",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-03-07to2023-03-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://lipocine.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-03-07to2023-03-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://lipocine.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-23-007176-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-007176-xbrl.zip
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M:>AW$8L"E@J874+3(7:_7V_Z483[,>\S=>E%.??F'+U@]S=02P,$%     @
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MMC87 IP <.%!4+!J4BU@J[V33>+% HC/O$F?51'VI1KHB:X]03^F'%@&*X=
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MVA*G%?*4+U#CC+L[?;NIX8FY0_1BYBLA/'ZKNZIK.BN=>-57$:"E-#POR7C
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M]AO*14><%^.O)3Z1RKW41B0ZU9X?05#>[N)WVWHFYTKT6@@;^L>ZN%K\B*?
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MS[6[(&TI*DNY@"N&5)'0!X; &(P='X.A+Q0PH6!%NP4K<]T"]\*D.$&],RU
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M_X/SMP;G^QIMK_\)X.;4W5W]K""^/DANTY_0AK^II3^]_3=02P,$%     @
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M&N6S9VB"R;#8I[@Y8-3Q;'8@46$/ROB-^:^B76!K,]H7$#.S"\D$7NB7^YA
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M':HWFB.J@ K'^4)XM8-Y(M0ACL44C(>J1 /)=!T"ZA#0UMY<M6&NYN0TS,%
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M003BZ93!I'')&R!X7GF]<U3_(M"!?*;V/7/)Z6GC>:=M%I5WOOCXPD)VQQ=
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M+6,ZN%<!#WD\X=<#"(T)V$_%%;.</EDKP3295.6X$JD[;30!5:S7PZ%0S*@
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MZ%OW^X?"R-VI'XZ^=J[K[P5+_A]02P,$%     @ U$-J5F+;3EM2 P  N0P
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M%D*7-"U5/T6@BE43UQ*A>]$^FV$9C41 .=BNM*B:5_-VS6PQ& '7QT*.CF!
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MV#;L%EVP'KRH!9INJF:6?P%02P,$%     @ U$-J5AFK26C^"@  @(8  !4
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M;-\E=@5%OV$-!ZP, I)>>R8L(F <U2*0"D%%C%]LYEFV)?Q-\%A"/"$$F@=
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M>#,M,2YH=&U02P$"% ,4    " #40VI6H22:M045   &8@  "0
M    @ $K!P  97@S+3(N:'1M4$L! A0#%     @ U$-J5MC,@^\2#   @2L
M  H              ( !5QP  &5X.3DM,2YH=&U02P$"% ,4    " #40VI6
M( W77N4>   )Z0  "P              @ &1*   9F]R;3@M:RYH=&U02P$"
M% ,4    " #40VI68MM.6U(#  "Y#   $0              @ &?1P  ;'!C
M;BTR,#(S,#,P-RYX<V102P$"% ,4    " #40VI6&:M):/X*  " A@  %0
M            @ $@2P  ;'!C;BTR,#(S,#,P-U]L86(N>&UL4$L! A0#%
M  @ U$-J5F%Y9=58!P  U5<  !4              ( !458  &QP8VXM,C R
C,S S,#=?<')E+GAM;%!+!08     !P ' *0!  #<70     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
